Fluorogenic pH sensitive dyes and their method of use

Patent metadata

Field	Value
Publication number	US-9910051-B2
Application number	US-201414455550-A
Country	US
Kind code	B2
Filing date	Aug 8, 2014
Priority date	Oct 27, 2006
Publication date	Mar 6, 2018
Grant date	Mar 6, 2018

Abstract

A new class of pH sensitive fluorescent dyes and assays relating thereto are described. The dyes and assays are particularly suited for biological applications including phagocytosis and monitoring intracellular processes. The pH sensitive fluorescent dyes of the present invention include compounds of Formula I:

wherein the variables are described throughout the application.

First claim

What is claimed is:

1. A method for identifying a target cell within a population of cells whereby the target cell is differentially labeled as compared to neighboring cells within the population, the method comprising:
a) contacting the population of cells with a compound of Formula III conjugated to a protein or to a peptide, to form a contacted cell population

wherein R 3 is N(CH 3 ) 2 , R 4 is CH 2 CH 3 and R 5 comprises a reactive group conjugated with the protein or with the peptide, wherein the reactive group comprises an activated ester of a carboxylic acid, a sulfonyl halide, a tetrafluorophenyl ester, an isothiocyanate, a maleimide, a haloalkyl or a haloacetamide;

b) incubating the contacted cell population for a period of time sufficient for the conjugate to enter the target cell, thereby forming an incubated cell population; and
c) illuminating the incubated cell population, wherein the target cell is identified by increased fluorescence as compared to neighboring cells within the population.

2. The method of claim 1 , wherein the population of cells is part of a tissue.

3. The method of claim 2 wherein the tissue is selected from the group consisting of tumor tissue, epidermal tissue, muscle tissue, bone marrow tissue, neural tissue, brain tissue, organ tissue, and human biopsy tissue.

4. The method of claim 1 wherein the population of cells comprises blood cells, immune cells, or neurons.

5. The method of claim 1 wherein the reactive group of R 5 comprises an activated ester of a carboxylic acid conjugated with the protein or with the peptide.

6. The method of claim 5 wherein the activated ester of a carboxylic acid is a succinimidyl ester of a carboxylic acid conjugated with the protein or with the peptide.

7. The method of claim 1 wherein R 5 is (CH 2 ) 3 —NHS ester conjugated with the protein or with the peptide.

8. The method of claim 1 wherein the reactive group of R 5 comprises a sulfonyl halide conjugated with the protein or with the peptide.

9. The method of claim 1 wherein the reactive group of R 5 comprises a tetrafluorophenyl ester conjugated with the protein or with the peptide.

10. The method of claim 1 wherein the reactive group of R 5 comprises a maleimide conjugated with the protein or with the peptide.

11. A method comprising detecting a disease in a subject comprising:
incubating a sample obtained from the subject suspected of having the disease with a compound of Formula III conjugated to a carrier molecule associated with the disease, to form an incubated sample

where R 3 is N(CH 3 ) 2 , R 4 is CH 2 CH 3 and R 5 comprises a reactive group conjugated with the carrier molecule associated with the disease;

illuminating the incubated sample with an appropriate wavelength to form an illuminated sample; and
detecting fluorescent emissions from the illuminated sample;
wherein the fluorescent emissions are used to detect the disease.

12. The method of claim 11 wherein the reactive group of R 5 comprises an activated ester of a carboxylic acid conjugated with the carrier molecule.

13. The method of claim 12 wherein the activated ester of a carboxylic acid is a succinimidyl ester of a carboxylic acid conjugated with the carrier molecule.

14. The method of claim 11 wherein R 5 is (CH 2 ) 3 —NHS ester conjugated with the carrier molecule.

15. The method of claim 11 wherein the reactive group of R 5 comprises a maleimide conjugated with the carrier molecule.

16. The method of claim 11 wherein the incubating is for a sufficient amount of time for the compound to enter cells.

17. The method of claim 11 wherein the sample comprises a biological fluid that comprises endogenous host cells.

18. The method of claim 11 wherein the sample comprises blood cells, immune cells or neurons.

19. The method of claim 11 wherein the sample comprises muscle tissue, vascular tissue, saliva, or urine.

Assignees

• Life Technologies Corp

Inventors

• Beacham Daniel
• Dzubay Jeffrey
• Gee Kyle
• Martin Vladimir
• Rukavishnikov Aleksey

Classifications

• C09K11/06

  containing organic luminescent materials · CPC title

• C07D311/90

  with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9 · CPC title

• G01N2333/245

  Escherichia (G) · CPC title

• C07F5/02

  Boron compounds · CPC title

• G01N33/5005

  involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title